BMC Gastroenterol
- REIZNER J, Freuer D, Schmitz T, Linseisen J, et al
Depression and risk of gastro-oesophageal reflux disease (GERD): results from the
UK Biobank study.
BMC Gastroenterol. 2026 Jan 8. doi: 10.1186/s12876-025-04591.
- ATASOY H, Levent A
The effect of the use of proton pump inhibitors (PPI) on complications in
patients with cirrhosis.
BMC Gastroenterol. 2026 Jan 7. doi: 10.1186/s12876-025-04516.
Gut
- ZHENG B, Kobayashi H, Tu R, Huang K, et al
Gastrin-dependent expansion of Cck2r(+) corpus progenitors accelerates ulcer
healing and inhibits gastric dysplasia.
Gut. 2026;75:265-277.
Helicobacter
- PARRA P, Nyssen OP, Gisbert JP
Non-Bismuth Quadruple Concomitant Treatment for Helicobacter pylori Eradication:
A Systematic Review and Meta-Analysis.
Helicobacter. 2026;31:e70099.
- STERBENC A, Vratanar B, Mojskerc EM, Homan M, et al
An Open-Label Randomized Controlled Trial Comparing the Efficacy and Safety of a
7-Day Triple Therapy With Bismuth Versus 14-Day Standard Triple Therapy for
Helicobacter pylori Eradication in Children and Adolescents.
Helicobacter. 2026;31:e70103.
- EL-AZAB G, Abdel Salam S, Moustafa E, Abuoelhassan A, et al
Efficacy and Safety of Levofloxacin- Versus Moxifloxacin-Based Nitazoxanide
Quadruple Therapy as Second-Line Treatment for Helicobacter pylori in Egypt: A
Randomized Multicenter Trial.
Helicobacter. 2026;31:e70104.
- PATIL S, Sarkar S, Jobby R, Yu S, et al
Drug Repurposing Identifies Natamycin and Avacopan as Urease-Targeted Therapeutic
Candidates Against Helicobacter pylori.
Helicobacter. 2026;31:e70094.
- TEPES B, Bric TK, Oblak M, Zavrsnik J, et al
EUROHELICAN-Accelerating Gastric Cancer Reduction Through Helicobacter pylori
Eradication.
Helicobacter. 2026;31:e70097.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016